Synopsys (NASDAQ:SNPS) Price Target Raised to $620.00

Synopsys (NASDAQ:SNPS) had its price objective lifted by Rosenblatt Securities from $575.00 to $620.00 in a research note released on Thursday morning,Benzinga reports. Rosenblatt Securities currently has a buy rating on the semiconductor company’s stock.

Several other research firms also recently issued reports on SNPS. Zacks Research downgraded Synopsys from a “strong-buy” rating to a “hold” rating in a report on Friday, August 21st. BNP Paribas Exane upgraded Synopsys from an “underperform” rating to a “neutral” rating and set a $420.00 target price for the company in a report on Thursday, September 24th. Morgan Stanley dropped their target price on Synopsys from $525.00 to $500.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 19th. KeyCorp boosted their price target on shares of Synopsys from $600.00 to $605.00 and gave the stock an “overweight” rating in a research note on Thursday. Finally, HSBC cut shares of Synopsys from a “buy” rating to a “reduce” rating in a research report on Friday, September 25th. Seventeen analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $584.11.

Synopsys Stock Performance

Shares of SNPS stock opened at $489.90 on Thursday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. The firm has a market cap of $93.88 billion, a P/E ratio of 86.55, a P/E/G ratio of 2.68 and a beta of 1.21. The firm’s 50 day moving average price is $408.01 and its 200-day moving average price is $436.40. Synopsys has a one year low of $362.55 and a one year high of $539.48.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The company had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. During the same quarter in the previous year, the company earned $3.39 earnings per share. The firm’s quarterly revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, equities research analysts predict that Synopsys will post 10.97 EPS for the current year.

Insiders Place Their Bets

In related news, CEO Sassine Ghazi sold 14,604 shares of the stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total value of $5,474,747.52. Following the transaction, the chief executive officer owned 76,865 shares of the company’s stock, valued at $28,815,151.20. This represents a 15.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Aart de Geus sold 25,000 shares of the firm’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $441.76, for a total value of $11,044,000.00. Following the completion of the sale, the insider owned 120,421 shares in the company, valued at approximately $53,197,180.96. This represents a 17.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 89,245 shares of company stock valued at $37,992,919. Insiders own 0.56% of the company’s stock.

Institutional Investors Weigh In On Synopsys

Several hedge funds and other institutional investors have recently made changes to their positions in SNPS. Sankala Group LLC purchased a new position in Synopsys in the fourth quarter valued at approximately $25,000. Elevation Wealth Partners LLC lifted its position in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after buying an additional 27 shares during the last quarter. Osbon Capital Management LLC acquired a new position in shares of Synopsys in the 2nd quarter valued at $25,000. IMG Wealth Management Inc. acquired a new position in shares of Synopsys in the 2nd quarter valued at $28,000. Finally, Geneos Wealth Management Inc. grew its position in shares of Synopsys by 151.5% in the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 50 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Stronger fiscal 2027 outlook: Synopsys set a fiscal 2027 revenue target of approximately $11.15 billion, with growth and profit forecasts reportedly above Wall Street expectations. Management also outlined a long-term growth target of roughly 15%, reinforcing expectations that demand for chip-design and engineering software will remain strong as AI increases semiconductor complexity. Synopsys sets fiscal 2027 revenue target
• Positive Sentiment: Major AI-related partnerships: A reported $1 billion, multiyear agreement with Amazon, along with a new OpenAI partnership, should expand Synopsys’ role in custom silicon, AI-chip development and design automation. Investors viewed the agreements as validation of the company’s position as an AI infrastructure beneficiary. Synopsys stock jumps on OpenAI and AWS deals
• Positive Sentiment: Analyst support and capital returns: Deutsche Bank raised its price target by $50 to $640, while Rosenblatt increased its target from $575 to $620 and maintained a buy rating. Bank of America and KeyBanc also reportedly lifted their targets. Synopsys additionally announced plans for a $1 billion share repurchase. Deutsche Bank raises Synopsys price target
• Positive Sentiment: Broader growth opportunity: The Ansys acquisition expands Synopsys beyond traditional electronic design automation into system-level modeling and multiphysics simulation, potentially increasing its addressable market over time. Synopsys AI and Ansys create a growth story

About Synopsys

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company’s offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.